Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hyperthermia × Paclitaxel × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 56 Carcinoma, Non-Small-Cell Lung 40 Triple Negative Breast Neoplasms 22 Ovarian Neoplasms 20 Fallopian Tube Neoplasms 17 Neoplasm Metastasis 14 Squamous Cell Carcinoma of Head and Neck 13 Lung Neoplasms 12 Endometrial Neoplasms 12 Stomach Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Esophageal Neoplasms 9 Colorectal Neoplasms 9 Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Carcinoma 6 Uterine Cervical Neoplasms 5 Inflammatory Breast Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Peritoneal Neoplasms 4 Pancreatic Neoplasms 4 Melanoma 4 Head and Neck Neoplasms 4 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Lung Diseases 3 Hypopharyngeal Neoplasms 3 Cholangiocarcinoma 3

Interventions

Paclitaxel 1 Carboplatin 1 AC protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05889390 2024-12-03

NeoHTerMa

Semmelweis University

Phase 2/3 Active not recruiting

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡